This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of biologically active molecules. It is particularly valuable in the creation of compounds targeting neurological disorders, such as Alzheimer's disease and Parkinson's disease, due to its structural compatibility with receptors in the central nervous system. Additionally, it serves as a building block in the design of potential therapeutic agents for cancer treatment, where its piperidine and benzothiazole moieties contribute to binding affinity and selectivity. Its application extends to organic synthesis, where it is used to develop novel heterocyclic compounds with potential pharmacological properties.